A Phase 2 Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism
Clinical trial NCT06988670 · RECRUITING
Trial details
- NCT number
- NCT06988670
- Sponsor
- Extend Biosciences Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-05
- Primary completion
- 2027-05-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.